Search

Your search keyword '"Brett, Gordon"' showing total 109 results

Search Constraints

Start Over You searched for: Author "Brett, Gordon" Remove constraint Author: "Brett, Gordon"
109 results on '"Brett, Gordon"'

Search Results

1. Comparison of telehealth and supervised phase III cardiac rehabilitation in regional Australia: protocol for a non-inferiority trial

4. Both caffeine and Capsicum annuum fruit powder lower blood glucose levels and increase brown adipose tissue temperature in healthy adult males

8. Quality of zirconia crowns, following prep-guide, and dentist-technician communication

13. Reliability and validity of clinical tests of cardiorespiratory fitness: A systematic review and meta-analysis

14. Technology Based Supportive Care for Metastatic Breast Cancer Patients

19. The Diffusion of Culture and Cognition Within and Beyond Sociology, 1997–20211.

20. The Diffusion of Culture and Cognition Within and Beyond Sociology, 1997–20211.

21. Discrepancies Exist between Exercise Prescription and Dose in Elite Women’s Basketball Pre-Season

22. DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma—A phase 3 randomized trial.

23. Efficacy of programmed cell death protein 1 (PD1) inhibitors in cutaneous squamous cell carcinoma (cSCC) patients with large nerve-perineural invasion (LN-PNI): A multicenter retrospective study.

26. Both caffeine and

27. Service and demographic factors, health, trauma exposure, and participation are associated with adjustment for former Australian Defense Force members

29. The Effect of Match Schedule on Accelerometry-Derived Exercise Dose during Training Sessions throughout a Competitive Basketball Season

31. Efficacy of programmed cell death protein 1 (PD1) inhibitors in cutaneous squamous cell carcinoma (cSCC) patients with large nerve-perineural invasion (LN-PNI): A multicenter retrospective study

33. Who Thinks How? Social Patterns in Reliance on Automatic and Deliberate Cognition

34. Randomized trial of radiotherapy with weekly cisplatin or cetuximab in low risk HPV associated oropharyngeal cancer (TROG 12.01): A Trans-Tasman Radiation Oncology Group study.

35. DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma—A phase 3 randomized trial.

36. KEYNOTE-629: Health-related quality of life (HRQoL) with pembrolizumab (pembro) in patients (pts) with locally advanced (LA) or recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC).

42. CD68+ tumor-associated myeloid cells as the target of adenosine-induced gene products and predictor of response to adenosine blockade with ciforadenant (cifo) in renal cell cancer (RCC).

43. Phase II study of cemiplimab in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC): Longer follow-up.

44. Pembrolizumab (P) or P + chemotherapy (C) versus EXTREME (E) as first-line (1L) therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): analysis of KEYNOTE-048 by disease state.

45. KEYNOTE-048: Progression after the next line of therapy following pembrolizumab (P) or P plus chemotherapy (P+C) vs EXTREME (E) as first-line (1L) therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

46. Adenosine receptor blockade with ciforadenant +/- atezolizumab in advanced metastatic castration-resistant prostate cancer (mCRPC).

47. Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

48. KEYNOTE-629: Phase 2 study of pembrolizumab for recurrent/metastatic or locally advanced unresectable cutaneous squamous cell carcinoma (cSCC).

50. Phase 2 study of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with metastatic cutaneous squamous cell carcinoma (mCSCC; Group 1): 12-month follow-up.

Catalog

Books, media, physical & digital resources